News
Hosted on MSN2mon
FDA Approves Groundbreaking Rapid-Acting Insulin Biosimilar Merilog, Offering New Hope for Millions Battling DiabetesWASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Merilog (insulin-aspart-szjj ... use and a 10-milliliter multiple-dose vial—providing versatile options ...
Biphasic insulin aspart 30/70 was ... patient's needs; the dose was adjusted individually as required, based on the physician's decision (mean initial dose was 25.96 IU, 0.37 IU/kg).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results